Delivery Order SPE2DB20D3303-SPE2DB25FA0DX

Award Date 6/12/25
Potential Completion Date 7/7/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $10,662.57 delivery order contract is for the medication TAGRISSO 80 MG TABLET 30S. The contract is a firm fixed-price, non-set-aside award with a completion date of July 3, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a $10,538.79 Firm Fixed Price Delivery Order for the supply of TAGRISSO 80 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of February 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of TAGRISSO 80 MG TABLET 30S. The contract has a firm fixed price of $10,662.57 and is not set aside. It has an ultimate completion date of June 11, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $90,841.23 in firm fixed-price delivery orders for the supply of TAGRISSO 80 MG TABLET 30S, a specialty medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of August 4, 2022 and was awarded on July 14, 2022. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $10,662.57 delivery order contract is for the supply of the pharmaceutical product Tagrisso 80 mg tablet 30s. The contract is a firm fixed-price, non-set-aside award with a completion date of June 11, 2025. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,538.79 firm fixed-price delivery order is for the medication TAGRISSO 80 MG TABLET 30S, with a completion date of March 15, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,247.06 firm-fixed-price delivery order is for the supply of the drug TAGRISSO 80 MG TABLET 30S, with a completion date of June 21, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,662.57 firm-fixed-price delivery order is for the supply of TAGRISSO 80 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of March 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the prescription drug TAGRISSO 80 MG TABLET 30S to the Defense Logistics Agency (DLA). The $21,077.60 firm fixed price delivery order has an ultimate completion date of June 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $21,325.14 firm fixed price delivery order is for the supply of TAGRISSO 80 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of June 20, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB25FA0DX
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of the prescription medication TAGRISSO 80 MG TABLET 30S. The $10,662.57 firm fixed-price delivery order contract has a completion date of July 7, 2025 and is not set aside.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 9/11/25, 10:49 AM